A memorial project for the Massachusetts Mental Health Center


    Mary Anne Badaracco, M.D., Associate Professor of Psychiatry, HMS; Head of the Department of Psychiatry, Beth Israel Deaconess Medical Center. Dr. Badaracco played a major role in teaching at MMHC before leaving to become Chair at BIDMC; she is still an active teacher and leader of the Longwood Program in Psychiatry.

    James Beck, M.D., Ph.D. , Professor of Psychiatry, Harvard Medical School Acting Chair; HMS Dept Psychiatry at MMHC. Dr. Beck's entire career has been devoted to Public Sector Psychiatry, in the Court Clinics and at Cambridge Hospital where he was vice chair. Dr. Beck has published extensively in the area of forensic psychiatry.

    Michael J. Bennett, M.D., Associate Clinical Professor of Psychiatry, HMS; Faculty, Beth Israel-Deaconess Hospital Department of Psychiatry. Dr. Bennett was one of the founders of the department of psychiatry upon its inception at Harvard Community Health Plan. He has played a leading role in the development of psychiatry in managed care programs. His book "The Empathic Healer" is an important contribution to contemporary psychiatric treatment.

    Mona Bennett, M.D., Assistant Professor of Psychiatry, HMS. Dr. Bennett was Deputy Commissioner of Mental Health for Massachusetts and played a significant role in improving patient care throughout the state. Dr. Bennett is a recipient of the Outstanding Psychiatrist Award for Advancement of the Profession from the Mass. Psychiatric Society.

    Deanna Brooks, MSW, Clinical Associate Professor and Director of Field Education, Simmons College School of Social Work. Ms. Brooks had a long affiliation with MMHC before assuming her current academic position. She was Chief Social Worker, Out Patient Psychiatry, 1980-1983; Acting Director of Social Service, 1978 79, 1981 82; Chief Social Worker, Inpatient Psychiatry Unit, 1974 1978; Staff Social Worker, Inpatient and Outpatient Units, 1970 1974. She has coauthored chapters and journal articles on case management in social work, and the impact of managed care on social work student field training.

    Elizabeth Childs, M.D., Commissioner, Department of Mental Health, Commonwealth of Massachusetts. Dr. Childs was Chief of Psychiatry at Carney Hospital and Past President of the Massachusetts Psychiatric Society before assuming her present position. She is a strong advocate for treatment of those who are most in need.

    James Dalsimer, M.D. , Clinical Instructor in Psychiatry, HMS; Supervising Psychiatrist, MMHC; Training and Supervising Analyst, Boston Psychoanalytic Institute. Dr. Dalsimer was a Chief Resident at MMHC, and has been a stalwart of the teaching and supervision program for his entire career.

    Ken Duckworth, M.D. , Assistant Professor of Psychiatry, HMS; Medical Director, National Alliance for the Mentally Ill. While serving on the MMHC faculty, Dr. Duckworth became the Deputy Commissioner for Clinical and Professional Services Massachusetts Department of Mental Health where he fostered the community outreach and treatment for the homeless programs that he created while at MMHC. He has received awards from both local and national consumer groups for his advocacy and clinical work.

    James Feldman, M.D., M.P.H., Assistant Professor of Psychiatry, MMHC. Dr. Feldman is currently Medical Director of MMHC and the Bay Cove Mental Health Center. His career has been devoted to treatment of the most severely and persistently mentally ill patients.

    Robert Goisman, M.D., Assistant Professor of Psychiatry, HMS; Associate Director, Harvard Longwood Psychiatry Residency Training Program; Director of Residency Training and Medical Student Education at MMHC. Dr. Goisman has been affiliated with Massachusetts Mental Health Center and with Harvard Medical School since 1979 and is a national expert on the cognitive-behavioral treatment of anxiety disorders. He has written articles and conducted research on psychiatric education, psychosocial rehabilitation and community psychiatry, as well as on the treatment of anxiety disorders

    Jill M. Goldstein, Ph.D., Associate Professor of Psychiatry at the Massachusetts Mental Health Center and Consultant in Neuroscience (Psychiatry) at Massachusetts General Hospital., Dr. Goldstein is Director of Research on Women's Mental Health at MMHC. Over the last 17 years, she has developed the MMHC-MGH Program of Research on the Clinical Neuroscience of Sex Differences in the Brain. She is an internationally recognized expert on identifying and understanding the impact of one's sex on the nature of schizophrenia and on normal sex differences.

    Alan Green, M.D., Raymond Sobel Professor of Psychiatry, and Chairman, Department of Psychiatry Dartmouth Medical School. For the 29 years before assuming his present position at Dartmouth, Dr. Green's entire career was spent at MMHC. Among his many positions, he was the first Center Director of the Commonwealth Research Center at MMHC from its founding until 2002, when he left to become Chair of the Department of Psychiatry at Dartmouth Medical School. He also served as director of the Neuropsychopharmacology Labaoratory at MMHC. His interests have been in studies of patients with schizophrenia and related psychiatric disorders as well as the mechanism of atypical and novel antipsychotic drugs, and the pharmacotherapy of schizophrenia and co-occurring substance use disorders.

    Jon Gudeman, M.D., Professor Psychiatry and Behavioral Medicine, Medical College of Wisconsin. Dr. Gudeman is a former Medical Director at MMHC. He developed the Day Hospital-Inn program at MMHC which became a model for mental health care throughout the U.S. Currently, Director for the Medical College of Wisconsin Center for Psychotherapies at Columbia Hospital, he is the former Director of Mental Health for Milwaukee County. Dr. Gudeman has advocated for increased public financing of mental health care. He has taught courses in psychopathology and psychodynamic therapy for students in many disciplines.

    Thomas Gutheil, M.D., Professor of Psychiatry, HMS, Associate Director, Program in Psychiatry and the Law, MMHC Revered for his outstanding teaching, Dr. Gutheil is a prolific author of books and journal articles, and the recipient of numerous awards for teaching and outstanding career contributions to forensic psychiatry and the psychiatric aspects of jurisprudence

    Sondra Helman, R.N., C.S, Ms. Helman was for many years Director of Continuing Care and then the Center Director for MMHC. She is a passionate advocate for seriously mentally ill patients and played a major role in developing outreach and housing programs for the most severely ill MMHC patients overseeing the expansion of supervised housing from 12 beds to 400. She led the merger of the Continuing Care Service with Southard Clinic, Latino Services and Positive Aging Services and created five integrated multidisciplinary clinical teams. She has received several awards from MMHC and from the Department of Mental Health for her pioneering work.

    J. Allan Hobson, M.D. , Professor of Psychiatry, HMS; Program Director, Cognitive Neuroscience of Sleep and Dreaming Dr. Hobson's entire distinguished career has been at MMHC. He is a world authority and pioneer in research on the neurophysiology and neurochemistry of sleep and dreams. His current research interests focus on cognitive neuroscience.

    David Hoffman, M.D., Clinical Instructor in Psychiatry, HMS; Medical Director of the Metro-Boston Division of the Department of Mental Health. Dr. Hoffman was a chief resident at MMHC and then rapidly assumed positions of leadership in the Massachusetts Department of Mental Health. He is an outstanding clinician as well as administrator, committed to improving outpatient mental health care in Massachusetts.

    Joel Kleinman, MD, Ph.D , Chief, Section on Neuropathology, Clinical Brain Disorders Branch, NIMH Dr. Kleinman is a world authority and pioneering researcher in brain anatomy and chemistry of schizophrenia. He combined psychiatry training at MMHC with subsequent neurology training and articulates the importance of his good clinical training in residency at MMHC as a solid basis for subsequent neuroscience research.

    Linda Larson, M.A., Substance Abuse Counselor; co-facilitator of the Sobriety Support Group at MMHC, Editor of Spare Change News, 1997-2002, member of the Coalition to Save Mass Mental. She has published articles in the Boston Globe and the New Yorker's "Letters to the Editor" Page advocating for the mentally ill, and has received three awards for her advocacy from the Statehouse and one from MMHC. She has been a client at MMHC since 1986.

    Robert McCarley, M.D., Professor of Psychiatry HMS and Chair of the Harvard Department of Psychiatry, Brockton/West Roxbury VAMC Director of Neuroscience Laboratory and VA Center for Basic and Clinical Neuroscience Studies of Schizophrenia. Dr. McCarley is a world leader in schizophrenia research, as well as in sleep and dream neurophysiology. His particular focus has been on identifying neurotransmission pathways and circuitry that may play a role in normal cognition, and in disorders such as schizophrenia.

    Andrew P.Morrison, M.D., Associate Clinical Professor of Psychiatry at Harvard Medical School. For many years after residency at MMHC, Dr. Morrison supervised residents in Southard Clinic, and directed the Continuing Medical Education Program at MMHC. Currently he is on the faculties of the Boston Psychoanalytic Institute and the Massachusetts Institute for Psychoanalysis, where he is also Supervising Analyst. He has published several books on shame (Shame: The Underside of Narcissism and The Culture of Shame), and has written numerous professional articles.

    Clifford Robinson, MSW, M.Ed., Area Director, Department of Mental Health, Commonwealth of Massachusetts Mr. Robinson has led the reorganization of the Metro area of the Department of Mental Health through recent turbulent fiscal and political climates. He is a passionate advocate for treatment of the most severely and persistently mentally ill individuals.

    Laura Rood R.N., C.S., Laura came to MMHC in 1978. She initially worked in the Continuing Care Service where she was the Program Director for the original "Quarterway House". She then went on to be the Director of the Psychiatric Intensive Care Unit and eventually to be the Director of Nursing. She returns to MMHC as Center Director after a hiatus in NYC as Director of Psychiatric Nursing at Bellevue Hospital.

    Sheldon Roth, M.D., Assistant Clinical Professor of Psychiatry, HMS; Supervising psychiatrist, Beth Israel-Deaconess Hospital Department of Psychiatry; Training and Supervising Psychoanalyst at PINE. Following his chief residency at MMHC, Dr. Roth served as a "super chief" (Staff Visit) for many years. He is nationally known for his skills as a teacher and practitioner of psychotherapy and psychoanalysis. He is the author Psychotherapy: The Art of Wooing Nature. New York: Jason Aronson.

    James E. Sabin, M.D., Clinical Professor of Psychiatry HMS; Supervising Staff Psychiatrist, Harvard Vanguard Medical Associates. Following his training at MMHC, Dr. Sabin was one of the early psychiatrists in the Harvard Community Health Plan practice, where he founded the continuing care" program for patients with chronic psychiatric illness He has played a major role in creating a teaching program for MMHC psychiatric trainees in the managed care setting and has written extensively on issues related to psychiatric care and ethics in managed care settings.

    Carl Salzman, M.D., Professor of Psychiatry, HMS; Director of Psychopharmacology, Director of Education, Massachusetts Mental Health Center. During his career, all spent at MMHC, Dr. Salzman has held virtually all clinical positions, but is best known as Director of Psychopharmacology since 1979. Recognized internationally for his research on the treatment serious mental disorders in late life, he is best known for his skills as a teacher of psychiatry. He is the recipient of many national and local teaching and research awards, most recently the national "Teacher of the Year" award in 2003.

    Alan F. Schatzberg, M.D., Kenneth T. Norris, Jr. Professor and Chairman, Department of Psychiatry and Behavioral Sciences Stanford University School of Medicine. Prior to assuming his position at Stanford in 1991, Dr. Schatzberg was Co-Director of the Affective Disorders Program (with Dr. J. Cole), as well as Director of the Depression Research Facility at Mclean Hospital. He then returned to MMHC as Clinical Director of the Massachusetts Mental Health Center and Professor of Psychiatry at Harvard Medical School before moving to Stanford. He is a world leader in affective disorders research and is one of the most well known psychiatrists in the US.

    Richard Shelton, M.D., James G. Blakemore Professor of Psychiatry and Associate Professor of Psychopharmacology, Vanderbilt University; Chief of the Adult Psychiatry Division at Vanderbilt University School of Medicine; Senior Fellow at the John F. Kennedy Center for Research on Human Development. Since his chief residency at MMHC, Dr. Shelton has become a world leader in affective disorders research. He is an investigator in the Center for Molecular Neuroscience at Vanderbilt University, where his current research interests include: signal transduction abnormalities in depressive disorders; neurogenomics of depression; causes of and treatment for depression, both unipolar and bipolar disorders..

    Joseph J. Schildkraut, M.D., Professor of Psychiatry, HMS; Founding Director of the Neuropsychopharmacology/Psychiatric Chemistry Laboratory, MMHC. Dr. Schildkraut's is a world leader in affective disorders research; his seminal paper, The Catecholamine Hypothesis of Affective Disorders, published in 1965, set the agenda for biological research on depression and psychopharmacology research for the next 25 years. He must be considered one of the "pioneers" of modern psychiatric research. Dr. Schildkraut has also been exploring the interrelatedness of depression, spirituality, and artistic creativity.

    Larry Seidman, Ph.D., Assoc. Professor of Psychiatry, HMS; Director, Commonwealth Research Center; Associate Chair for Research Massachusetts Mental Health Center. Dr. Seidman has conducted research and published extensively on information processing, brain structure and function, and the biological vulnerability to schizophrenia and ADHD. He is internationally known for defining the cognitive deficits in schizophrenia and the impact of medication on these deficits.

    Miles F. Shore, M.D., Bullard Professor of Psychiatry at Harvard Medical School, Visiting Scholar at the Kennedy School of Government at Harvard and Senior Consultant at Harvard Medical International. In 1975 he became the Bullard Professor of Psychiatry and served as Superintendent of the Massachusetts Mental Health Center from then until June 30, 1993. At the Kennedy School, Dr. Shore teaches about health care policy and leadership to degree students and is co-director of "Skills for the New World of Health Care". At Harvard Medical International he is developing executive education programs on health policy in Switzerland and other countries, and is co-Director of Biosecurity 2003, an international conference on response to threats of bioterrorism.

    Elizabeth Simpson, M.D., Clinical Instructor in Psychiatry, HMS; Director of the Dialectical Behavior Therapy program at MMHC. Before joining the MMHC faculty, Dr. Simpson created and ran the Women's Partial Program at Butler Hospital in Providence, RI, an innovative 5-day DBT program for women with personality disorders and other treatment resistant conditions. Her program at MMHC offers partial hospital, outpatient, and residential DBT services to chronically mentally ill people with borderline personality disorder.

    Ming Tsuang, MD, Ph.D, D.Sc., University Professor, University of California; Director, Institute of Human Behavioral Genomics, Department of Psychiatry, UCSD. Dr. Tsuang is one of the world's most distinguished psychiatric researchers. From 1985 until 2003, he served as the Stanley Cobb Professor of Psychiatry and director of MMHC and the MMH Institute as well as director of the Harvard Institute of Psychiatric Epidemiology and Genetics at the Harvard Medical School and School of Public Health. Dr. Tsuang's expertise is family-genetic studies of psychiatric disorders, especially the genetic heterogeneity of schizophrenia. He conducts large-scale investigations of the genetic and environmental bases for variations in clinical features, response to treatment, and neuropsychological abnormalities. The ultimate goals are to identify people at risk for mental disorders and to prevent their occurrence.

    Russell Vasile, M.D., Associate Professor of Psychiatry, HMS; Director of Affective Disorders program, Beth Israel Deaconess Department of Psychiatry. Following his chief residency at MMHC, Dr. Vasile's played a major role in teaching and research at MMHC before moving to the BIDMC. His research and publications have been in the areas of assessment and psychopharmacologic treatment of affective disorders and anxiety disorders

    Robert Waldinger, M.D., Associate Professor of Psychiatry HMS; Research Psychiatrist at BWH and JBCC. Dr. Waldinger served as Director or Residency and Training at MMHC and is currently is one of the leading teachers in the Longwood Residency Training program. He is Principal Investigator "The Close Relationships Project: Psychology and Psychophysiology of Emotion Regulation in Intimate Adult Relationships". With George Vaillant, Dr. Waldinger is studying the marriages of his cohorts of men who have been followed since adolescence and are now in their late 70s and early 80s. He is the recipient of several awards for excellence in teaching.

    Daniel R. Weinberger, M.D., Director, genes cognition and psychosis Program, NIMH; Chief, Clinical Brain Disorders Branch, NIMH. A former chief resident at MMHC, Dr. Weinberger went on to conduct seminal research in the neurobiology of schizophrenia at NIMH. His research group consistently reports discoveries leading to more refined theories and treatments for schizophrenia. He is, arguably, the world's best known theoretician and researcher in schizophrenia.

    June G. Wolf, Ph.D., Assistant Clinical Professor of Psychology, HMS; .Director of Psychology and Director Clinical Psychology Internship Program, and the Southard Clinic, MMHC. Dr. Wolf has been active in the teaching of psychotherapy and psychiatric diagnosis at MMHC for decades. Under her direction, the MMHC psychology internship has maintained national prominence in clinical training with special focus on severe mental illness. As Director of Southard Clinic, she is responsible for providing adequate breadth of psychotherapy experience for residents and interns.